Table 1 Comparison of two groups baseline clinical data and changes in metabolic data recorded after treatment between two groups of newly diagnosed T2DM patients

Age

47.52 ± 11.72

47.18 ± 11.54

Sex (M/F)

19/12

17/16

BMI (kg/m²)

26.12 ± 3.14

26.70 ± 3.06

Weight (kg)

76.53 ± 15.21

77.52 ± 12.79

FBG (mmol/L)

8.31 ± 2.11

7.69 ± 1.54

HbA1C(%)

8.54 ± 1.50

8.14 ± 1.42

CHO-L (mmol/L)

5.10 ± 1.69

5.13 ± 1.66

LDL-C (mmol/L)

3.39 ± 0.95

3.32 ± 0.81

TG (mmol/L)

2.07 ± 1.00

2.16 ± 1.17

UA (umol/L)

339.70 ± 89.74

340.70 ± 92.13

Cr (umol/L)

62.87 ± 16.49

60.19 ± 12.63

BUN (umol/L)

6.76 ± 2.89

5.68 ± 1.59

ALT (IU/L)

23.51 ± 9.29

24.86 ± 11.37

AST (IU/L)

23.12 ± 8.72

22.79 ± 10.05

SBP (mmHg)

125.20 ± 9.28

128.80 ± 15.43

DBP (mmHg)

79.00 ± 8.79

81.33 ± 11.30

UACR (mg/g)

10.84 ± 5.87

12.26 ± 4.78

eGFR (ml/(min.1.73m²))

109.60 ± 17.03

110.90 ± 15.14